Filter your results
- 3
- 2
- 1
- 3
- 1
- 1
- 1
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
TP53, XPO1 and ATM Mutations Exclusive Distribution in the Adverse Prognosis Chronic Lymphocytic Leukemia (CLL) GroupSOHO, Sep 2018, Houston (Texas), United States. 18, pp.S218, 2018, ⟨10.1016/j.clml.2018.07.084⟩
Conference poster
inserm-03950185v1
|
||
|
Prevalence, distribution and predictive value of XPO1 mutation in a real‐life chronic lymphocytic leukaemia cohortBritish Journal of Haematology, 2020, 191 (3), pp.e90-e94. ⟨10.1111/bjh.17046⟩
Journal articles
hal-03942496v1
|
||
|
IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibitionBlood, 2023, 142 (2), pp.158-171. ⟨10.1182/blood.2022017948⟩
Journal articles
hal-04191646v1
|